Press Release
Jan 11, 2022
Considering the ongoing concerns caused by Coronavirus Disease (COVID-19) and the global surge in Omicron cases, the IASLC’s primary focus is to ensure the health and welfare of attendees and faculty at all IASLC meetings and activities. Due to this evolving situation, including the possibility that travel restrictions and limitations on large gatherings will persist, the IASLC is transitioning the 2022 Targeted Therapies of Lung Cancer Meeting (TTLC22) scheduled for February 23-26, 2022, in Santa Monica, California to a fully virtual worldwide event.
We are working on a virtual experience that will be both interesting and engaging. Please note the date change and join us virtually from February 22-26, 2022, as we are planning a robust agenda, with shorter days full of practice-changing science to accommodate more members' schedules. Those who have already registered for the in-person event will be automatically registered for the Worldwide Virtual Event and will receive a refund for the difference in registration fees for the virtual event. Additional details and instructions will be sent to conference faculty, registered delegates, and commercial supporters shortly.
The TTLC22 meeting will include both live stream interaction and on-demand content. Our primary goal is to ensure that educational and scientific content is available to all interested participants while protecting the health and well-being of attendees and faculty.
The IASLC is committed to offering quality experiences that continue to provide opportunities for attendee engagement that have been a hallmark of the IASLC’s in-person conferences. The IASLC will continue to deliver on its fundamental mission by bringing critical education in all aspects of thoracic cancer to the widest possible audience. Additional details, dates, and program information for the other 2022 meetings will be routinely updated on the IASLC website, the official source of updates to all IASLC meetings and events.
We recognize that many of our global and multidisciplinary members and meeting attendees are healthcare workers who are on the front line of studying, diagnosing, and treating lung cancer. We want to express our gratitude and admiration to you and to all health care professionals working in incredibly difficult circumstances to contain this outbreak and prevent further loss of life.
We hope to see you online from February 22-26, 2022. Even though we are physically apart, we are still together as a community, connected by a shared passion for conquering thoracic cancers and malignancies worldwide and fostering the best outcomes for our patients.
The IASLC and its members have created a reference concerning this evolving health situation. For up-to-date COVID-19 resources, CLICK HERE. For future updates to this statement, visit the IASLC Website.
Please don’t hesitate to contact us with any questions or concerns at info@iaslc.org.